Probiotic Weizmannia coagulans MTCC 5856 as adjunct therapy in children's acute diarrhea—a randomized, double-blind, placebo-controlled study
ObjectivesAcute diarrhea in children is generally managed by replacing the lost fluid with oral rehydration solution (ORS). Probiotic supplementation has been reported to reduce the severity of diarrhea. In the present study, we investigated the effect of Weizmannia coagulans (Bacillus coagulans) MT...
Main Authors: | Muhammed Majeed, Kalyanam Nagabhushanam, Sivakumar Arumugam, Nagarjuna Chadalavada, Jyotsna Seepana, Thumjaa Annamalai, Avinash Murali, Priji Prakasan, Lakshmi Mundkur |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2023.1338126/full |
Similar Items
-
Skin Protective Activity of LactoSporin-the Extracellular Metabolite from <i>Bacillus Coagulans</i> MTCC 5856
by: Muhammed Majeed, et al.
Published: (2020-09-01) -
Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study
by: Muhammed Majeed, et al.
Published: (2018-07-01) -
Weizmannia coagulans: an ideal probiotic for gut health
by: Shiqi Zhang, et al.
Published: (2024-01-01) -
Screening, Identification and Biological Characterization of Weizmannia coagulans BC66
by: Sufen KONG, et al.
Published: (2023-08-01) -
In vitro and in vivo evaluation of efficacy and safety of Weizmannia coagulans HOM5301 for boosting immunity
by: Shiqi Zhang, et al.
Published: (2023-08-01)